![The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants - Ao - 2023 - MedComm - Wiley Online Library The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants - Ao - 2023 - MedComm - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/12a0395f-e8f0-4635-978c-cce0664c768a/mco2239-fig-0003-m.jpg)
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants - Ao - 2023 - MedComm - Wiley Online Library
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![COVID-19 Continues to Evolve with the XBB Variant; FDA Advisory Panel Recommends Fall Vaccine Targeting XBB - Tash.org COVID-19 Continues to Evolve with the XBB Variant; FDA Advisory Panel Recommends Fall Vaccine Targeting XBB - Tash.org](https://tash.org/wp-content/uploads/2023/09/2023-Jun-23-CDC-COVID-variants.png)
COVID-19 Continues to Evolve with the XBB Variant; FDA Advisory Panel Recommends Fall Vaccine Targeting XBB - Tash.org
![Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant - The Lancet Regional Health – Western Pacific Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant - The Lancet Regional Health – Western Pacific](https://www.thelancet.com/cms/attachment/a3a741fa-ad99-4460-98ac-4fdccf5f06ae/gr1.jpg)
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant - The Lancet Regional Health – Western Pacific
![FDA recommends Covid-19 vaccine manufacturers make single-strain boosters that target Omicron spinoff XBB.1.5 for the fall | CNN FDA recommends Covid-19 vaccine manufacturers make single-strain boosters that target Omicron spinoff XBB.1.5 for the fall | CNN](https://media.cnn.com/api/v1/images/stellar/prod/230516072013-covid19-pfizer-vaccine-file-121520.jpg?c=original)